Annalise Critical Care AI is an unclaimed profile.
If you work at Harrison.ai, sign up or log in to claim the profile today.
Harrison.ai Logo
Harrison.ai

Annalise Critical Care AI

Annalise Critical Care AI is an FDA-cleared clinical triage solution designed to identify and prioritize urgent findings on chest X-rays (CXR) and non-contrast head CTs (NCCTB). It supports radiologists by flagging 11 high-risk conditions—such as tension pneumothorax and obstructive hydrocephalus—enabling faster reporting and time-to-care, especially during low staffing periods like nights and weekends.

Overview

Product Overview

Security and Compliance Certifications: FDA Approval
Annalise Critical Care AI is an FDA-cleared clinical triage solution designed to identify and prioritize urgent findings on chest X-rays (CXR) and non-contrast head CTs (NCCTB). It supports radiologists by flagging 11 high-risk conditions—such as tension pneumothorax and obstructive hydrocephalus—enabling faster reporting and time-to-care, especially during low staffing periods like nights and weekends. The system integrates into existing radiology workflows and is customizable to different clinical thresholds, helping optimize turnaround times without interrupting radiologist processes.

Customers Served

Hospital / Health System
Ambulatory Practice

Categories

Company Info

HQ Location
Haymarket, NSW, Australia
Founded
2018
Headcount
51-200
Total Funding
$120.7M
Latest Round
Series C
Latest Round
07/01/2024

Company Socials

LinkedIn
X
Crunchbase
YouTube
Vimeo
GitHug

Demos

Similar Products

CARPL logo
CARPL

CARPL

Company Info
Founded: 2018
Headcount: 11-50
Customers
Verified Customers: 5
Customers Served: Hospital / Health System, Ambulatory Practice
Product Overview
Security and Compliance Certifications: ISO 27001, HIPAA
CARPL provides a radiology AI platform that simplifies the integration, validation, and deployment of AI solutions within radiology departments. It offers access to over 110 AI applications from various vendors, enabling integration with existing PACS and RIS systems. The platform is designed to support scalable AI deployments, streamline workflows, and enhance diagnostic accuracy by providing a unified interface for managing AI solutions across different radiology tasks.
Cleerly logo
Cleerly

Cleerly

Company Info
Founded: 2017
Customers
Verified Customers: 1
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: HIPAA, SOC 2 Type 2
Cleerly is an AI-based digital care platform for the diagnosis of heart disease. It utilizes coronary computed tomography angiography (CCTA) to provide analyses of atherosclerosis, plaque buildup and stenosis, through machine learning algorithms. The technology creates 3D models of coronary arteries for early heart disease detection and treatment plans. It includes the Cleerly Proxy and Cleerly ISCHEMIA for coronary artery disease.
Envisionit Deep AI logo
Envisionit Deep AI

Envisionit Deep AI

Company Info
Founded: 2019
Headcount: 11-50
Customers
Customers Served: Hospital / Health System, Ambulatory Practice
Product Overview
Security and Compliance Certifications: FDA Approval
Envisionit Deep AI develops AI-driven radiology solutions, including RADIFY for automated image analysis and RATify for real-time AI model monitoring. Their tools are designed to assist radiologists with triaging and diagnostic support, particularly for critical conditions like pneumothorax and pleural effusion. The platform supports applications in teleradiology, training, and research, aiming to enhance diagnostic accuracy and accessibility.